Dr. Carlos Leónidas Leiva is a biotechnologist with expertise in the research of biologicals for therapeutic and diagnostic use. In particular, his PhD project focused on the development of egg yolk antibodies to neutralize animal toxins. This project was carried out with the participation of two major scientific institutions from Argentina, the National Institute of Agricultural Technology (INTA) and the National Laboratories and Health Institutes Administration (ANLIS). As a post-doc, he worked in the production of monoclonal antibody biosimilars at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Italy. Currently, he is an imπACT postdoc at VUB working at the interface of environmental sciences, immunology, and technology transfer.
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
